بیماری های قلبی
شنبه# #،# #24# #تیر# #1402
| Harding, D., Chong, M. H., Lahoti, N., Bigogno, C. M., Prema, R., Mohiddin, S. A., & Marelli‐Berg, F. (2023). Dilated cardiomyopathy and chronic cardiac inflammation: Pathogenesis, diagnosis and therapy. Journal of Internal Medicine, 293(1), 23-47. |
| Xu, C. M., Karbasiafshar, C., Brinck Teixeira, R., Ahsan, N., Blume Corssac, G., Sellke, F. W., & Abid, M. R. (2023). Proteomic Assessment of Hypoxia-Pre-Conditioned Human Bone Marrow Mesenchymal Stem Cell-Derived Extracellular Vesicles Demonstrates Promise in the Treatment of Cardiovascular Disease. International Journal of Molecular Sciences, 24(2), 1674. |
| Attar, A., Monabati, A., Montaseri, M., Vosough, M., Hosseini, S. A., Kojouri, J., ... & Ramzi, M. (2022). Transplantation of mesenchymal stem cells for prevention of acute myocardial infarction induced heart failure: Study protocol of a phase III randomized clinical trial (Prevent-TAHA8). Trials, 23(1), 1-7. |
| White, I. A., Sanina, C., Balkan, W., & Hare, J. M. (2016). Mesenchymal stem cells in cardiology. Mesenchymal Stem Cells: Methods and Protocols, 55-87. |
| Golpanian, S., Wolf, A., Hatzistergos, K. E., & Hare, J. M. (2016). Rebuilding the damaged heart: mesenchymal stem cells, cell-based therapy, and engineered heart tissue. Physiological reviews, 96(3), 1127-1168. |
